Monitoring of antimicrobial resistance of Acinetobacter baumannii in the intensive care unit of a hospital from 2010 to 2013
10.3969/j.issn.1671-9638.2016.02.009
- VernacularTitle:某院重症医学科2010-2013年鲍曼不动杆菌耐药性监测
- Author:
Jinrong WANG
;
Pan GAO
;
Zhaobo CUI
;
Hongli DU
;
Shuhong LIU
;
Xiuling GAO
;
Shufen GUO
- Publication Type:Journal Article
- Keywords:
intensive care unit;
Acinetobacter baumannii;
drug resistance,microbial;
rational drug use;
drug re-sistance
- From:
Chinese Journal of Infection Control
2016;15(2):108-110
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the isolation rates and antimicrobial resistance of Acinetobacter baumannii (AB) from intensive care unit (ICU)between 2010 and 2013,and provide evidence for clinical anti-infective therapy. Methods The isolation and antimicrobial resistance of AB from ICU between 2010 and 2013 were analyzed retro-spectively.Results A total of 1 413 pathogenic strains were isolated,556(39.35%)of which were AB,isolation rates in each year were 39.45%,41 .35%,29.44%,and 40.53% respectively.AB were mainly isolated from lower respiratory tract (75.72%).Antimicrobial susceptibility testing results showed that AB had low resistance rates to cefoperazone/sulbactam(5.85%)and amikacin (17.45%);detection rates of multidrug-resistant and extensively drug-resistant AB increased from 9.63% and 3.70% to 42.50% and 31 .88%,respectively (both P < 0.001 ). Conclusion AB is the common pathogen in ICU,antimicrobial resistance is serious,isolation of multidrug-resistant and extensively drug-resistant AB increased year by year;intensifying the monitoring of drug resistance is helpful for the treat-ment and prevention of AB infection.
